Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • Power of Women 2024
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

vaccine efficacy

Covid-19 vaccines still protect against severe illness from the Omicron variant
Coronavirus
/ 29 November 2021

Covid-19 vaccines still protect against severe illness from the Omicron variant

The vast majority of hospital admissions in Gauteng are of unvaccinated people, data from the National Institute for Communicable Diseases shows

By Eunice Masson
How well is Pfizer’s Covid jab working in SA? We break down some of the data
Coronavirus
/ 9 July 2021

How well is Pfizer’s Covid jab working in SA? We break down some of the data

A local analysis found early evidence of promising protective effects of the Pfizer vaccine in South Africa — even among those who had received only one dose

By Ryan Noach
Rise of the variants: What you need to know about the Delta variant in SA
Coronavirus
/ 28 June 2021

Rise of the variants: What you need to know about the Delta variant in SA

SA’s lockdown regulations are tightening to better curb the spread of Covid-19, amid concerns that the Delta variant could drive a surge of infections

By Aisha Abdool Karim
The EVDS will schedule your appointments six weeks apart. Here’s why
Coronavirus
/ 21 June 2021

The EVDS will schedule your appointments six weeks apart. Here’s why

South Africa has doubled the interval for the second dose of the Pfizer vaccine. We take a look at what other countries have done and the evidence for the move

By Aisha Abdool Karim and Joan Van Dyk
South Africa’s not reaching herd immunity. Our new goal is containment
Coronavirus
/ 4 June 2021

South Africa’s not reaching herd immunity. Our new goal is containment

South Africa’s stop-start roll-out is not the only reason herd immunity is unrealistic for 2021. A constrained vaccine supply and new variants also play a role

By Bhekisisa Team

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }